Growth Metrics

Cytosorbents (CTSO) Net Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.11%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4,440.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -163.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -163.87%
Dec 31, 2025 14.02%
Sep 30, 2025 -14.52%
Jun 30, 2025 -2.12%
Mar 31, 2025 75.72%
Dec 31, 2024 -149.33%
Sep 30, 2024 69.89%
Jun 30, 2024 32.67%
Mar 31, 2024 16.89%
Dec 31, 2023 2,102.15%
Sep 30, 2023 24.65%
Jun 30, 2023 43.44%
Mar 31, 2023 18.30%
Dec 31, 2022 91.77%
Sep 30, 2022 -90.45%
Jun 30, 2022 -132.58%
Mar 31, 2022 -115.13%
Dec 31, 2021 -1,273.27%
Sep 30, 2021 -662.90%
Jun 30, 2021 -63.15%
Mar 31, 2021 -20.71%
Dec 31, 2020 82.84%
Sep 30, 2020 87.80%
Jun 30, 2020 19.18%
Mar 31, 2020 29.30%
Dec 31, 2019 26.91%
Sep 30, 2019 -129.14%
Jun 30, 2019 39.06%
Mar 31, 2019 -63.77%
Dec 31, 2018 -71.69%
Sep 30, 2018 -46.27%
Jun 30, 2018 -235.59%
Mar 31, 2018 -95.56%
Dec 31, 2017 35.85%
Sep 30, 2017 6.12%
Jun 30, 2017 42.28%
Mar 31, 2017 16.96%
Dec 31, 2016 -46.58%
Sep 30, 2016 23.15%
Jun 30, 2016 -309.52%
Mar 31, 2016 61.07%
Dec 31, 2015 37.79%
Sep 30, 2015 -90.04%
Jun 30, 2015 177.38%
Mar 31, 2015 -383.75%
Dec 31, 2014 -377.25%
Sep 30, 2014 -55.30%
Jun 30, 2014 -31.00%
Mar 31, 2014 40.14%
Dec 31, 2013 -109.69%
Sep 30, 2013 -47.98%
Jun 30, 2013 -35.11%
Mar 31, 2013 -14.18%
Dec 31, 2012 55.08%
Sep 30, 2012 62.29%
Jun 30, 2012 21.91%
Mar 31, 2012 -17.46%
Dec 31, 2011 -151.94%
Sep 30, 2011 -119.29%
Jun 30, 2011 -98.32%